Filter News
Area of Research
- (-) Materials for Computing (2)
- (-) Nuclear Science and Technology (3)
- Biological Systems (1)
- Biology and Environment (102)
- Biology and Soft Matter (1)
- Clean Energy (60)
- Climate and Environmental Systems (5)
- Computational Biology (2)
- Computational Engineering (2)
- Computer Science (1)
- Electricity and Smart Grid (1)
- Functional Materials for Energy (1)
- Fusion and Fission (3)
- Isotopes (6)
- Materials (22)
- Mathematics (1)
- National Security (7)
- Neutron Science (19)
- Supercomputing (38)
News Topics
- (-) Biomedical (4)
- (-) Environment (2)
- 3-D Printing/Advanced Manufacturing (8)
- Advanced Reactors (11)
- Bioenergy (2)
- Biology (1)
- Chemical Sciences (4)
- Climate Change (1)
- Composites (1)
- Computer Science (9)
- Coronavirus (4)
- Cybersecurity (1)
- Decarbonization (2)
- Energy Storage (4)
- Fusion (8)
- Isotopes (6)
- Materials (10)
- Materials Science (18)
- Microscopy (4)
- Molten Salt (4)
- Nanotechnology (7)
- National Security (1)
- Neutron Science (10)
- Nuclear Energy (36)
- Physics (2)
- Polymers (6)
- Quantum Computing (1)
- Quantum Science (3)
- Security (1)
- Simulation (1)
- Space Exploration (6)
- Summit (1)
- Sustainable Energy (6)
- Transformational Challenge Reactor (3)
- Transportation (5)
Media Contacts
Scientists at Oak Ridge National Laboratory and the University of Tennessee designed and demonstrated a method to make carbon-based materials that can be used as electrodes compatible with a specific semiconductor circuitry.
Four research teams from the Department of Energy’s Oak Ridge National Laboratory and their technologies have received 2020 R&D 100 Awards.
The Department of Energy’s Office of Science has selected three Oak Ridge National Laboratory scientists for Early Career Research Program awards.
Oak Ridge National Laboratory researchers have discovered a better way to separate actinium-227, a rare isotope essential for an FDA-approved cancer treatment.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.